• No results found

University of Groningen Survivorship care after testicular cancer Boer, Hindrik

N/A
N/A
Protected

Academic year: 2021

Share "University of Groningen Survivorship care after testicular cancer Boer, Hindrik"

Copied!
9
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

University of Groningen

Survivorship care after testicular cancer

Boer, Hindrik

IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below.

Document Version

Publisher's PDF, also known as Version of record

Publication date: 2019

Link to publication in University of Groningen/UMCG research database

Citation for published version (APA):

Boer, H. (2019). Survivorship care after testicular cancer: New insights in late effects of treatment and approaches to shared-care follow-up. Rijksuniversiteit Groningen.

Copyright

Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons).

Take-down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum.

(2)

109

Easy navigating through the forest

of survivorship care

Chapter 6

6

Hink Boer, Janine Nuver, Joop D. Lefrandt, Arjan W. Duijzer*, Sophie Bunskoek, Annette J. Berendsen, Sabine Siesling**, Jourik A. Gietema Departments of Medical Oncology, General Practice and Vascular Medicine, University Medical Center Groningen, University of Groningen, the Netherlands, *Nxt Step, the Netherlands, **Comprehensive Cancer Center the Netherlands

Journal of Clinical Oncology. 2014; 32: 61-62

Comment on: Carla Parry, Erin E. Kent, Laura P. Forsythe, Catherine M. Alfano and Julia H. Rowland, Can’t See the Forest for the Care Plan: A Call to Revisit the Context of Care Planning, 2013, J Clin Oncol. 31: 2651-3

(3)
(4)

111 To the editor

With great interest we have read the article by Carla Parry and colleagues. Based on the report of the Institute of Medicine Committee on Survivorship Care and, more recently, the ASCO Survivorship Care statement, it is strongly recommended to provide cancer patients with a treatment summary and follow-up plan to guide their necessary aftercare.1,2 Parry et al. clearly state that experiences with survivorship care plans (SCPs) up to now have had limited success.3,4 Survivors of adult-onset cancers often lack a high-quality health care plan. Moreover, SCP’s are not integrated well into processes of care coordination. By focusing too much on the care plan as a document summarizing the treatment we tend to forget the primary goal of a plan in general: guiding follow-up care to ensure that survivors receive the appropriate care after cancer treatment.

Parry et al. propose a very elucidating conceptual framework based on the past years of survivorship care research and organization (figure 1). They advocate the embedding of SCP’s within the context of models of care, processes of care, and technology platforms. Contemporary technology platforms should be used to generate and share SCP’s and support patient-centered care planning and patient-provider communication.

We absolutely embrace this idea of integrating electronically available information in the process of compiling SCPs. Many of the theoretical concepts that comprise the framework of Parry et al. are put into practice in the Survivor App, a mobile application we recently developed5 (Figure 1). The Survivor App serves as a carrier for a digital personal SCP. Patients become increasingly accustomed to handling digital data by using websites and smartphones. With this personal SCP at their fingertips, the survivors not only know what care needs to be provided, but also when, where and by whom (e.g. oncologist, nurse practitioner or primary care physician).

Currently, the generation of SCPs is the limiting step in the organization of patient- centered survivorship care. Patients receive complex cancer treatments with known late effects but resources are often simply insufficient to summarize this information in patient-friendly documents. Collecting relevant diagnosis and treatment data and reporting this in a paper document is a time-consuming process. In addition, even if these documents can be provided they often lack time-specific follow-up plans, which impairs care coordination between patients and multiple care providers.

For this Survivor App a selection of relevant data is derived by the treating oncologist from the patients’ health records. The data is entered in a web-based plan generator. Algorithms based on existing guidelines are used to personalize care plans depending on the individual diagnosis, co-morbidity and treatment characteristics. The data is subsequently encoded in a QR code that can be scanned with the Survivor App by the patient, directly from the computer screen of their oncologist. This technology not only ensures convenient data transfer from physician to patient, but also limits security risks. The technology can be made available to oncology centers in the Netherlands and other countries. The SCP can be printed on paper for patients without a smartphone.

During follow-up, the Survivor App allows patients to keep track of different appointments. This enables patients to be optimally in control and co-manage their own follow-up and offers the Easy navigating through the forest of survivorship care

(5)

possibilities of individualized education and healthy lifestyle support. The information describes the goal of follow-up assessments and redirects to online resources and communities.

Parry et al. underscore the importance of evaluation of survivorship care. This app is being evaluated as part of a trial of a shared-care survivorship care program for testicular cancer patients who are subjected to an intense follow-up schedule after treatment with chemotherapy for metastatic disease (ClinicalTrials.gov ID NCT01783145). Both the patients’ primary care physician and oncologist receive a copy of the SCP, extended with additional information on patterns of disease recurrence, late effects, and cardiovascular risk management. Due to the long-standing curability of testicular cancer, the research on late effects of treatment in these survivors is extensive and well-organized6,7 Testicular cancer patients still function as a model for a curative treatment of advanced cancer.

The steadily growing population of cancer survivors should have the best available survivorship care. Simple and smart instruments like the Survivor App can help survivors easy navigate their follow-up based on a personal plan, which is executed in conjunction with other caregivers. As such, the Survivor App fits perfectly into the Parry framework. Survivor care should combine the expertise of several disciplines. This app will accommodate easy navigation through the “forest of survivorship care” with the patient in control.

(6)

113 Easy navigating through the forest of survivorship care

Figure 1. Parry’s conceptual framework put into practice.

Generation Navigation Evaluation

Technology Platforms Web-based survivorship care plan

generator

iPhone app for patients as carrier for plan Plan is imported via

QR-code Processes of Care

Testicular cancer End-of-treatment summary Care plan is discussed with patient at

start of follow-up

Models of Care Shared-care follow-up or oncologist-only

In shared-care oncologist visits are alternated with family doctor visits

Care coordination Communication Patient-provider Provider-provider

Figure 1. Parry's conceptual framework about survivorship care planning and corresponding application into practice by

the Survivor App.

What, when, where and by whom? Care plan enables patient to

navigate through survivor care Patient is provided with

overview of follow-up: Oncological surveillance Management of long-term and

late effects

Evaluation Every follow-up plan is centrally monitored on a continuous basis Evaluation of the model of care

and prevention of duplication of services Psychosocial interventions based

on questionnaires

Framework by Parry et al.

Illustration of the end-of-treatment summary ( ) and survivorship care plan (➡)

Application by Boer et al.

Interventions Cardiovascular risk factor

management Psychosocial interventions

(7)

Chapter 6

References

Hewitt M, Greenfield S, Stovall E (eds). From cancer patient to cancer survivor: lost in transition. Washington, DC: National Academies Press, 2006, Chapter 4, p 151-153

McCabe MS, Bhatia S, Oeffinger KC et al: American Society of Clinical Oncology statement: achieving high-quality cancer survivorship care. J Clin Oncol. 31: 631-640, 2013

Grunfeld E, Julian JA, Pond G, et al: Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol 29: 4755-4762, 2011 4. Stricker CT, Jacobs LA, Risendal B, et al: Survivorship care planning after the institute of medicine recommendations: how are we faring? J Cancer Surviv;5: 358-370, 2011

https://itunes.apple.com/us/app/survivor-care/id519370277?mt=8

Travis LB, Beard C, Allan JM, et al: Testicular cancer survivorship: research strategies and recommendations. J Natl Cancer Inst 102: 1114-1130, 2010

Haugnes HS, Bosl GJ, Boer H, et al: Long-term and late effects of germ cell testicular cancer treatment and implications for follow-up. J Clin Oncol 30: 3752-3763, 2012

1 2 3 4 5 6 7

(8)
(9)

Referenties

GERELATEERDE DOCUMENTEN

Patients homozygous or heterozygous variant for SNP rs523349 have an odds ratio of 2.56 for the metabolic syndrome after treatment for metastatic testicular cancer compared

Metastatic TC patients with a high-risk vascular fingerprint before start of (B)EP chemotherapy developed arterial vascular events more often (19% vs. 2%).. During chemotherapy

We launched and made available a mobile application and the accompanying SCP generator, which can be easily used to offer survivors and their healthcare providers a clear

Therefore, we designed a survivorship care program for testicular cancer survivors to test the safety and feasibility of shared-care follow-up together with the PCP, and compared

Ideally, each cancer survivor should receive survivorship care that is adjusted to his or her diagnosis and treatment plan and personal risk profile, based on

Het is van potentieel belang om patiënten met een hoger risico op cardiovasculaire complicaties tijdens chemotherapie te identificeren, bij voorkeur voorafgaand aan de

Sjoukje Lubberts en Lars Steggink, dank voor de soepele samenwerking bij de verschillende studies en veel succes met de afronding van jullie proefschriften.. Nynke

Gietema JA, Sleijfer DT, Willemse PH, et al: Long-term follow-up of cardiovascular risk factors in patients given chemotherapy for disseminated nonseminomatous testicular cancer..